Related Experiment Videos
Quantitative analysis of T2 signal intensities in Alzheimer's disease
1Columbia University, New York State Psychiatric Institute, New York 10032, USA. rparsey@neuron.cpmc.columbia.edu
Abstract:
Hypointensities (focal areas of decreased signal intensity) have been reported on T2 weighted magnetic resonance images (MRI) in normal aging and in some neurological disease processes. Increased concentrations of iron have been suggested as one cause of these hypointensities. In Alzheimer's Disease, data suggests that there is both a disruption in iron metabolism as well as the presence of T2 hypointensities. We endeavored to determine if the decreased signal intensities could be quantitatively determined and, if so, in what regions, in an effort to establish a non-invasive biological marker and diagnostic aide. We performed a quantitative analysis of the T2 signal intensities in 13 MRIs from AD patients and 16 age- and sex-matched control subjects. We found that while there were statistically significant differences in the intensities of the putamen and red nucleus, these differences were small. We were unable to detect differences in intensities in a whole slice or the frontal lobe. To our knowledge this is the first quantitative comparison of MRI signal intensities in Alzheimer's Disease.
Insights
Researchers quantitatively analyzed T2 signal intensities in Alzheimer's Disease (AD) patients and controls. While small differences were found in specific brain regions, this study did not establish MRI signal intensity as a reliable non-invasive biomarker for AD.
Area of Science:
- Neuroimaging
- Neurology
- Biomarkers
Background:
- T2 hypointensities on magnetic resonance imaging (MRI) are observed in normal aging and neurological diseases.
- Increased iron concentration is a suspected cause of these hypointensities.
- Alzheimer's Disease (AD) is associated with disrupted iron metabolism and T2 hypointensities.
Purpose of the Study:
- To quantitatively determine T2 signal intensities in AD patients and controls.
- To identify specific brain regions exhibiting altered signal intensities.
- To explore the potential of MRI signal intensity as a non-invasive diagnostic marker for AD.
Main Methods:
- Quantitative analysis of T2 signal intensities from 13 AD patients and 16 age/sex-matched controls.
- Comparison of MRI signal intensities across different brain regions.
Main Results:
- Statistically significant but small differences in T2 signal intensities were observed in the putamen and red nucleus.
- No significant differences in T2 signal intensities were detected in whole-slice or frontal lobe analyses.
- This is the first quantitative comparison of MRI signal intensities in AD.
Conclusions:
- Current quantitative MRI T2 signal intensity analysis shows limited potential as a non-invasive biomarker for Alzheimer's Disease.
- Further research may be needed to refine methods or explore other imaging techniques for AD diagnosis.